pipette
ENEnglish

A public human population of TRAV26+ type II natural killer T cells recognises CD1d in a lipid-independent manner

Kean Chan Yew Poa, Christopher M. Harpur, Tan‐Yun Cheng, Elena Batleska, Catriona Vi Nguyen-Robertson, Rajesh Lamichhane, Alison A. White, Geovane Marques-Ferreira, Caroline Soliman, Scott JJ Reddiex, Christopher Menne, Adam P. Uldrich, D. Branch Moody, Jamie Rossjohn, Dale Ian Godfrey, Daniel Grant Pellicci, Jérôme Le Nours, Catarina F. Almeida

Revista con revisión por pares

En palabras de los autores

Abstract Most studies of CD1d-restricted natural killer T cells (NKT) have focused on type I TRAV10-TRAJ18 + NKT cells that recognise the glycolipid α-GalCer. Our understanding of type II NKT cells, their T cell receptor (TCR) gene usage, and their ligand specificity and diversity remains unclear. Here, using CD1d tetramers carrying diverse endogenous lipids (CD1d-endo), we identified public human TRAV26 + type II NKT TCRs present in all examined individuals, with many expressing a conserved TRAV26-2-TRAJ48 TCRα chain. Cellular, molecular and lipidomic analyses showed that TRAV26 + TCRs bound with similar affinities to CD1d loaded with diverse lipids, suggesting lipid-independent binding. Crystal structures of TRAV26 + TCR-CD1d complexes suggested these TCRs bound solely to the A’-roof of CD1d, distal to the protruding lipid. Collectively, we have uncovered a population of public lipid-independent TRAV26 + type II NKT cells.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 9 de octubre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-78124-5